{"id":297899,"date":"2023-12-14T22:17:32","date_gmt":"2023-12-15T04:17:32","guid":{"rendered":"https:\/\/endirecto.mx\/?p=297899"},"modified":"2023-12-14T22:17:40","modified_gmt":"2023-12-15T04:17:40","slug":"una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel","status":"publish","type":"post","link":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/","title":{"rendered":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel"},"content":{"rendered":"<p>Una vacuna experimental creada conjuntamente por las farmac\u00e9uticas Moderna y Merck, aplicada junto a un tratamiento de inmunoterapia de la segunda empresa, consigui\u00f3 reducir en 49% el riesgo de fallecimiento o reca\u00edda en pacientes en una fase avanzada de melanoma, uno de los tipos de c\u00e1ncer de piel m\u00e1s mortales.<\/p>\n<p>La vacuna y el tratamiento (conocido este \u00faltimo como Keytruda) tambi\u00e9n redujeron en 62% el riesgo de met\u00e1stasis en pacientes en un estadio avanzado de c\u00e1ncer de piel, que participaron en un ensayo de tres a\u00f1os llevado a cabo por ambas compa\u00f1\u00edas, seg\u00fan un comunicado de Moderna.<\/p>\n<p>Unas horas despu\u00e9s de darse a conocer la noticia, las acciones de Moderna subieron 11.47%, aunque las de Merck cayeron 0.25%.<\/p>\n<p>El director ejecutivo de Moderna, Stephane Bancel, asegur\u00f3 esta ma\u00f1ana al programa de\u00a0<em>CNBC<\/em>\u00a0&#8216;Squawk Box&#8217;, que la vacuna podr\u00eda llegar en 2025 a algunos pa\u00edses y que ambas farmac\u00e9uticas est\u00e1n estudiando su eficacia en pacientes en fases m\u00e1s tempranas de este tipo de c\u00e1ncer y en otros tumores.<\/p>\n<p>La vacuna est\u00e1 pensada para \u00abentrenar\u00bb al sistema inmunitario para que detecte y ataque las c\u00e9lulas tumorales.<\/p>\n<p>De acuerdo al comunicado, los efectos secundarios m\u00e1s comunes detectados hasta el momento en este tratamiento son la fatiga, escalofr\u00edos y dolor en el \u00e1rea donde se ha inyectado la vacuna.<\/p>\n<p>La vacuna est\u00e1 elaborada con \u00e1cido ribonucleico mensajero (mRNA, por sus siglas en ingl\u00e9s), una mol\u00e9cula que tanto Moderna como Pfizer ya usaron en sus respectivas vacunas contra el coronavirus, para las que se basaron precisamente en estudios previos sobre la efectividad de esta tecnolog\u00eda en el tratamiento contra el c\u00e1ncer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Una vacuna experimental creada conjuntamente por las farmac\u00e9uticas Moderna y Merck, aplicada junto a un tratamiento de inmunoterapia de la segunda empresa, consigui\u00f3 reducir en 49% el riesgo de fallecimiento o reca\u00edda en pacientes en una fase avanzada de melanoma, uno de los tipos de c\u00e1ncer de piel m\u00e1s mortales. La vacuna y el tratamiento [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[64,45],"tags":[336,337],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto\" \/>\n<meta property=\"og:description\" content=\"Una vacuna experimental creada conjuntamente por las farmac\u00e9uticas Moderna y Merck, aplicada junto a un tratamiento de inmunoterapia de la segunda empresa, consigui\u00f3 reducir en 49% el riesgo de fallecimiento o reca\u00edda en pacientes en una fase avanzada de melanoma, uno de los tipos de c\u00e1ncer de piel m\u00e1s mortales. La vacuna y el tratamiento [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\" \/>\n<meta property=\"og:site_name\" content=\"EnDirecto\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-15T04:17:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-15T04:17:40+00:00\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\"},\"author\":{\"name\":\"Redacci\u00f3n\",\"@id\":\"https:\/\/endirecto.mx\/#\/schema\/person\/dde6640ff345d098eddc857909489755\"},\"headline\":\"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel\",\"datePublished\":\"2023-12-15T04:17:32+00:00\",\"dateModified\":\"2023-12-15T04:17:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\"},\"wordCount\":306,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/endirecto.mx\/#organization\"},\"keywords\":[\"Featured\",\"Principal\"],\"articleSection\":[\"Internacional\",\"Portada\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\",\"url\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\",\"name\":\"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto\",\"isPartOf\":{\"@id\":\"https:\/\/endirecto.mx\/#website\"},\"datePublished\":\"2023-12-15T04:17:32+00:00\",\"dateModified\":\"2023-12-15T04:17:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/endirecto.mx\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/endirecto.mx\/#website\",\"url\":\"https:\/\/endirecto.mx\/\",\"name\":\"EnDirecto\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/endirecto.mx\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/endirecto.mx\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/endirecto.mx\/#organization\",\"name\":\"EnDirecto\",\"url\":\"https:\/\/endirecto.mx\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/endirecto.mx\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/endirecto.mx\/wp-content\/uploads\/2023\/09\/Logo-Endirecto.png\",\"contentUrl\":\"https:\/\/endirecto.mx\/wp-content\/uploads\/2023\/09\/Logo-Endirecto.png\",\"width\":991,\"height\":236,\"caption\":\"EnDirecto\"},\"image\":{\"@id\":\"https:\/\/endirecto.mx\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/endirecto.mx\/#\/schema\/person\/dde6640ff345d098eddc857909489755\",\"name\":\"Redacci\u00f3n\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/endirecto.mx\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b26bd563e32054845690841955845bb6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b26bd563e32054845690841955845bb6?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n\"},\"sameAs\":[\"http:\/\/endirecto.mx\"],\"url\":\"https:\/\/endirecto.mx\/author\/wrfwrfwf\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/","og_locale":"es_ES","og_type":"article","og_title":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto","og_description":"Una vacuna experimental creada conjuntamente por las farmac\u00e9uticas Moderna y Merck, aplicada junto a un tratamiento de inmunoterapia de la segunda empresa, consigui\u00f3 reducir en 49% el riesgo de fallecimiento o reca\u00edda en pacientes en una fase avanzada de melanoma, uno de los tipos de c\u00e1ncer de piel m\u00e1s mortales. La vacuna y el tratamiento [&hellip;]","og_url":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/","og_site_name":"EnDirecto","article_published_time":"2023-12-15T04:17:32+00:00","article_modified_time":"2023-12-15T04:17:40+00:00","author":"Redacci\u00f3n","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3n","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#article","isPartOf":{"@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/"},"author":{"name":"Redacci\u00f3n","@id":"https:\/\/endirecto.mx\/#\/schema\/person\/dde6640ff345d098eddc857909489755"},"headline":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel","datePublished":"2023-12-15T04:17:32+00:00","dateModified":"2023-12-15T04:17:40+00:00","mainEntityOfPage":{"@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/"},"wordCount":306,"commentCount":0,"publisher":{"@id":"https:\/\/endirecto.mx\/#organization"},"keywords":["Featured","Principal"],"articleSection":["Internacional","Portada"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/","url":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/","name":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel - EnDirecto","isPartOf":{"@id":"https:\/\/endirecto.mx\/#website"},"datePublished":"2023-12-15T04:17:32+00:00","dateModified":"2023-12-15T04:17:40+00:00","breadcrumb":{"@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/endirecto.mx\/una-vacuna-de-moderna-y-merck-reduce-a-la-mitad-el-riesgo-de-recaida-en-cancer-de-piel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/endirecto.mx\/"},{"@type":"ListItem","position":2,"name":"Una vacuna de Moderna y Merck reduce a la mitad el riesgo de reca\u00edda en c\u00e1ncer de piel"}]},{"@type":"WebSite","@id":"https:\/\/endirecto.mx\/#website","url":"https:\/\/endirecto.mx\/","name":"EnDirecto","description":"","publisher":{"@id":"https:\/\/endirecto.mx\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/endirecto.mx\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/endirecto.mx\/#organization","name":"EnDirecto","url":"https:\/\/endirecto.mx\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/endirecto.mx\/#\/schema\/logo\/image\/","url":"https:\/\/endirecto.mx\/wp-content\/uploads\/2023\/09\/Logo-Endirecto.png","contentUrl":"https:\/\/endirecto.mx\/wp-content\/uploads\/2023\/09\/Logo-Endirecto.png","width":991,"height":236,"caption":"EnDirecto"},"image":{"@id":"https:\/\/endirecto.mx\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/endirecto.mx\/#\/schema\/person\/dde6640ff345d098eddc857909489755","name":"Redacci\u00f3n","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/endirecto.mx\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b26bd563e32054845690841955845bb6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b26bd563e32054845690841955845bb6?s=96&d=mm&r=g","caption":"Redacci\u00f3n"},"sameAs":["http:\/\/endirecto.mx"],"url":"https:\/\/endirecto.mx\/author\/wrfwrfwf\/"}]}},"_links":{"self":[{"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/posts\/297899"}],"collection":[{"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/comments?post=297899"}],"version-history":[{"count":1,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/posts\/297899\/revisions"}],"predecessor-version":[{"id":297900,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/posts\/297899\/revisions\/297900"}],"wp:attachment":[{"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/media?parent=297899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/categories?post=297899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/endirecto.mx\/wp-json\/wp\/v2\/tags?post=297899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}